Savara Inc Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Savara Inc (SVRA) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$447.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-11
- Savara Inc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$105.00K, a 125.24% decline year-over-year.
- Savara Inc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$342.00K, a 389.83% decline year-over-year.
- Savara Inc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $68.00K.
- Savara Inc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $61.00K, a 94.83% decline year-over-year.
- Savara Inc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$479.00K, a 243.41% decline from fiscal 2023.
- Savara Inc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $334.00K.
- Savara Inc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$610.00K.
- Savara Inc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2021 was -$937.00K, a 197.71% decline from fiscal 2020.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$447.00K 10-Q · filed 2026-08-11 | -$379.00K derived: sum of 3 quarters · filed 2026-08-11 | -$318.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$342.00K 10-Q · filed 2026-05-12 | -$274.00K derived: sum of 2 quarters · filed 2026-08-11 | -$213.00K derived: sum of 3 quarters · filed 2026-08-11 | $203.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $68.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-11 | $129.00K derived: sum of 2 quarters · filed 2026-08-11 | $545.00K derived: sum of 3 quarters · filed 2026-08-11 | $663.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $477.00K derived: sum of 2 quarters · filed 2025-11-12 | $595.00K 10-Q · filed 2025-11-12 | -$454.00K derived: sum of 4 quarters · filed 2026-03-13 |
| 2025-06-30 | $416.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $534.00K 10-Q · filed 2025-08-13 | -$515.00K derived: sum of 3 quarters · filed 2026-03-13 | $664.00K derived: sum of 4 quarters · filed 2026-03-13 |
| 2025-03-31 | $118.00K 10-Q · filed 2025-05-13 | -$931.00K derived: sum of 2 quarters · filed 2026-03-13 | $248.00K derived: sum of 3 quarters · filed 2026-03-13 | $110.00K derived: sum of 4 quarters · filed 2026-03-13 |
| 2024-12-31 | -$1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $130.00K derived: sum of 2 quarters · filed 2026-03-13 | -$8.00K derived: sum of 3 quarters · filed 2026-03-13 | -$479.00K 10-K · filed 2026-03-13 |
| 2024-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.04M derived: sum of 2 quarters · filed 2024-11-12 | $570.00K 10-Q · filed 2024-11-12 | $1.24M derived: sum of 4 quarters · filed 2025-03-27 |
| 2024-06-30 | -$138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$609.00K 10-Q · filed 2024-08-12 | $62.00K derived: sum of 3 quarters · filed 2025-03-27 | -$261.00K derived: sum of 4 quarters · filed 2025-03-27 |
| 2024-03-31 | -$471.00K 10-Q · filed 2024-05-09 | $200.00K derived: sum of 2 quarters · filed 2025-03-27 | -$123.00K derived: sum of 3 quarters · filed 2025-03-27 | -$281.00K derived: sum of 4 quarters · filed 2025-03-27 |
| 2023-12-31 | $671.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $348.00K derived: sum of 2 quarters · filed 2025-03-27 | $190.00K derived: sum of 3 quarters · filed 2025-03-27 | $334.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$323.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$481.00K derived: sum of 2 quarters · filed 2023-11-09 | -$337.00K 10-Q · filed 2023-11-09 | $665.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2023-06-30 | -$158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$14.00K 10-Q · filed 2023-08-10 | $988.00K derived: sum of 3 quarters · filed 2024-03-07 | $397.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2023-03-31 | $144.00K 10-Q · filed 2023-05-15 | $1.15M derived: sum of 2 quarters · filed 2024-03-07 | $555.00K derived: sum of 3 quarters · filed 2024-03-07 | -$170.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $411.00K derived: sum of 2 quarters · filed 2024-03-07 | -$314.00K derived: sum of 3 quarters · filed 2024-03-07 | -$610.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | -$591.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$1.32M derived: sum of 2 quarters · filed 2022-11-10 | -$1.61M 10-Q · filed 2022-11-10 | -$1.89M derived: sum of 4 quarters · filed 2023-03-30 |
| 2022-06-30 | -$725.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$1.02M 10-Q · filed 2022-08-11 | -$1.30M derived: sum of 3 quarters · filed 2023-03-30 | -$1.61M derived: sum of 4 quarters · filed 2023-03-30 |
| 2022-03-31 | -$296.00K 10-Q · filed 2022-05-11 | -$576.00K derived: sum of 2 quarters · filed 2023-03-30 | -$883.00K derived: sum of 3 quarters · filed 2023-03-30 | -$776.00K derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-12-31 | -$280.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$587.00K derived: sum of 2 quarters · filed 2023-03-30 | -$480.00K derived: sum of 3 quarters · filed 2023-03-30 | -$937.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$307.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$200.00K derived: sum of 2 quarters · filed 2021-11-12 | -$657.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$350.00K 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | -$457.00K 10-Q · filed 2021-05-13 | |||
| 2020-12-31 | $959.00K 10-K · filed 2022-03-30 | |||
| 2019-12-31 | -$217.00K 10-K · filed 2021-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |